CAT Flow Report
Analysis based on market close March 31, 2026
Flow Verdict
Watch next session: $790 Put OI and flow for downside conviction; Any defensive call buying near $700-$720
Flow Summary
Net premium: +$36.3M (misleading - dominated by one large bullish print)
P/C volume ratio: 1.11 — slight put lean
P/C OI ratio: 1.13 — moderate put lean in positioning
Notable Prints
Read-through: Given the high IV (39.9%) vs. ATM (46.9%), this is likely bought. A bet on a >7% move higher in 10 days, aligning with the expected move to $754.79.
Read-through: Clusters with the $760C, suggesting a concentrated bullish bet on the April 10th expiry, targeting the $750-$760 zone.
Read-through: A longer-dated, closer-to-the-money bet. The IV of 45.3% is near the term structure ATM (44.3%), suggesting a vanilla long call. This provides a bullish counterpoint to the nearer-term activity.
Read-through: Extremely aggressive bet, needing a >7% move in 2 days. Low probability, high leverage play. Could be a speculative buy or a spread leg sold against the 4/10 calls.
Institutional Positioning
Call additions: Aggressive OTM calls at $750/$760 for April, some $730 for June
Put additions: Significant premium flow into $790 puts (-$3M net), large OI at $700/$600 puts
GEX/DEX consistency: Mixed. Positive GEX (+$1.4M) suggests pinning, but large DEX (5.6M shares equiv) and bearish premium prints indicate underlying hedging pressure.
OI clusters: Major put walls at $700 (4,373 OI) and $600 (1,793 OI). Call wall at $810 (3,209 OI).
Hedging evidence: Strong evidence. The massive $3M net premium into $790 puts is a clear institutional-sized hedge or downside bet. OI concentration in deep puts ($480, $535, $540) also suggests longer-term protection.
Max pain context: Spot ($708.46) is pinned exactly at the nearest max pain ($708). The long-term max pain trend is sharply lower ($708 → $620), aligning with heavy put OI at lower strikes.
Signal vs Noise
Key Conclusions
Read the Flow analysis for CAT for 2026-03-31. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.